Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

As fund of fund assets grew $1.5bn in 18 months, Skybridge looks at opportunities in the MBS market

Thursday, November 29, 2012

From Komfie Manalo, Opalesque Asia:

Research driven alternative investment firm Skybridge Capital with approximately $6.7bn in assets saw its fund of fund assets grew by more than $1.5bn over the past 18 months and its Partner and the CEO Europe for SkyBridge Max von Bismarck is looking at opportunities in mortgage-backed securities that he described as attractive again.

As one of the panelists in the latest Opalesque 2012 Zurich Roundtable Von Bismarck said that Skybridge’s main positioning is with cash flow generative strategies that do not purely rely on mark to market appreciation. "For example, over the past two to three years we found the U.S. mortgage markets particularly attractive. One of the largest themes in our portfolios is the prepayment-sensitive MBS (mortgage-backed securities) markets, a super liquid $7tln market with very low hedge fund penetration of probably less than 1%. The market is mainly dominated by long-only mandate constrained players. We saw very interesting opportunities in terms of the carry streams and if we look at the last two years, this has been a major uncorrelated strategy that also generated attractive returns for us."

The Opalesque 2012 Zurich Roundtable was held in the office of Eurex and was sponsored by ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its